• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A commentary on the biology and growth kinetics of low-grade and high-grade gliomas.

作者信息

Hoshino T

出版信息

J Neurosurg. 1984 Nov;61(5):895-900. doi: 10.3171/jns.1984.61.5.0895.

DOI:10.3171/jns.1984.61.5.0895
PMID:6491735
Abstract

Cell kinetics studies of patients with various gliomas published in the past decade have shown that the average labeling index (LI) obtained from a pulse of 3H-thymidine is very high in medulloblastomas (12.0% +/- 1.3%, standard error of the mean) and glioblastoma multiforme (9.3% +/- 1.0%), low in well differentiated gliomas (less than 1%), and intermediate in anaplastic astrocytomas (4.0% +/- 0.8%). The higher the LI, the faster the tumor grows, probably reflecting a larger growth fraction. In tumor tissues obtained at autopsy, two glioblastomas diluted out the labeling compound in the 2- to 4-month interval after labeling, whereas three glioblastomas and two anaplastic astrocytomas retained labeled neoplastic cells for 3 weeks to 5 months. Most patients whose tumors contained foci of labeled cells at autopsy survived longer. Well differentiated gliomas harbored labeled cells for 2 1/2 to 7 years. These findings indicate that the kinetics of proliferation in well differentiated gliomas are different from those in glioblastomas or anaplastic astrocytomas.

摘要

相似文献

1
A commentary on the biology and growth kinetics of low-grade and high-grade gliomas.
J Neurosurg. 1984 Nov;61(5):895-900. doi: 10.3171/jns.1984.61.5.0895.
2
An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme.
Brain. 1980 Dec;103(4):967-84. doi: 10.1093/brain/103.4.967.
3
Cell kinetic analyses of human malignant brain tumors (gliomas).
Cancer. 1979 Sep;44(3):956-62. doi: 10.1002/1097-0142(197909)44:3<956::aid-cncr2820440325>3.0.co;2-c.
4
[A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].[脑肿瘤细胞动力学研究综述,特别参考抗溴脱氧尿苷单克隆抗体法]
No Shinkei Geka. 1984 Aug;12(9):1007-18.
5
Proliferative potential and outcome in pediatric astrocytic tumors.
J Neurooncol. 1992 Jul;13(3):277-82. doi: 10.1007/BF00172481.
6
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.IDH1 野生型间变性星形细胞瘤患者的预后比 IDH1 突变型胶质母细胞瘤差,IDH1 突变状态解释了高龄的不良预后影响:对胶质瘤分类的影响。
Acta Neuropathol. 2010 Dec;120(6):707-18. doi: 10.1007/s00401-010-0781-z. Epub 2010 Nov 19.
7
Biologic parameters that correlate with the prognosis of human gliomas.
Neuropathology. 2000 Sep;20(3):176-83. doi: 10.1046/j.1440-1789.2000.00329.x.
8
Variability in the proliferative potential of human gliomas.
J Neurooncol. 1989 Jul;7(2):137-43. doi: 10.1007/BF00165098.
9
Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.磁共振成像测定的脑血容量图与胶质瘤血管性的组织学及血管造影测定的相关性。
AJR Am J Roentgenol. 1998 Dec;171(6):1479-86. doi: 10.2214/ajr.171.6.9843274.
10
[Cell proliferation and glial fibrillary acidic protein in brain tumors].[脑肿瘤中的细胞增殖与胶质纤维酸性蛋白]
Acta Histochem. 1986;80(1):53-61.

引用本文的文献

1
Psychiatric Disease Preceding Intracranial Tumor Diagnosis: Investigating the Association.颅内肿瘤诊断前的精神疾病:探究两者之间的关联
Prim Care Companion CNS Disord. 2016 Dec 15;18(6). doi: 10.4088/PCC.16m02028.
2
Techniques to assess the proliferative potential of brain tumors.评估脑肿瘤增殖潜能的技术。
J Neurooncol. 2005 Aug;74(1):19-30. doi: 10.1007/s11060-004-5758-0.
3
Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.多形性胶质母细胞瘤患者采用综合治疗方法的临床预后因素多变量分析。
J Cancer Res Clin Oncol. 2003 Aug;129(8):477-84. doi: 10.1007/s00432-003-0471-5. Epub 2003 Jul 15.
4
Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.单克隆抗体MIB-1所定义的颅内脑膜瘤增殖率:与瘤周水肿及其他临床放射学和组织学特征的相关性
Neurosurg Rev. 2003 Jul;26(3):221-8. doi: 10.1007/s10143-003-0261-1. Epub 2003 Apr 8.
5
Prognostic significance of endothelial surface score and MIB-1 labeling index in glioblastoma.
J Neurooncol. 2000;46(1):11-6. doi: 10.1023/a:1006347919565.
6
Boswellic acids inhibit glioma growth: a new treatment option?波希鼠李糖醛酸抑制神经胶质瘤生长:一种新的治疗选择?
J Neurooncol. 2000;46(2):97-103. doi: 10.1023/a:1006387010528.
7
The role of image-guided technology in the surgical planning and resection of gliomas.影像引导技术在胶质瘤手术规划与切除中的作用。
J Neurooncol. 1999 May;42(3):247-58. doi: 10.1023/a:1006138609201.
8
A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.一项使用体内溴脱氧尿苷标记指数和计算机辅助恶性程度分级对胶质瘤进行的相关性研究。
Pathol Oncol Res. 1999;5(2):134-41. doi: 10.1053/paor.1999.0189.
9
Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity.慢性癫痫的低级别胶质瘤:一种独特的临床和病理实体。
J Neurooncol. 1997 Aug;34(1):79-84. doi: 10.1023/a:1005711321343.
10
The molecular biology of ependymomas.室管膜瘤的分子生物学
Brain Pathol. 1997 Apr;7(2):807-22. doi: 10.1111/j.1750-3639.1997.tb01066.x.